Diabetes sub model
|
Baseline incidence rate
|
0.0328368
|
Dimensionless/year
|
Calibration
|
Baseline progression rate [managed]
|
0.0134
|
Dimensionless/year
|
[49]
|
Baseline progression rate [unmanaged]
|
0.0556
|
Dimensionless/year
|
Baseline pre-diabetes regression rate
|
0.193
|
Dimensionless/year
|
[50]
|
Uptake rate of management
|
0.05
|
Dimensionless/year
|
Calibration
|
Hypertension sub-model
|
Baseline incidence rate
|
0.0237906
|
Dimensionless/year
|
Calibration
|
Baseline progression rate [unmanaged]
| | |
[51]
|
Female
|
0.06975
|
Dimensionless/year
|
Male
|
0.080125
|
Dimensionless/year
|
Effect of management on progression
|
0.33
|
Dimensionless/year
|
[52]
|
Baseline prehypertension regression rate
|
0.25
|
Dimensionless/year
|
[53]
|
Uptake rate of management
|
0.035
|
Dimensionless/year
|
Calibration
|
Smoking sub-model
|
Baseline smoking initiation rate
|
0.0082388
|
Dimensionless/year
|
Calibration
|
Baseline smoking relapse rate
|
0.1
|
Dimensionless/year
|
[56]
|
Baseline smoking cessation rate
|
0.162
|
Dimensionless/year
|
[55]
|
Demographics
|
Birth rate
|
Time series
|
Dimensionless/year
|
[47]
|
Net migration
|
Time series
|
Dimensionless/year
|
Calibration
|
Age specific mortality rate
|
Time series
|
Dimensionless/year
|
[47]
|
CVD Model
|
Smoking risk
| | |
[58]
|
Female
|
0.5419
|
Dimensionless
|
Male
|
0.5224
|
Dimensionless
|
Age risk
| | |
Female
|
0.0699
|
Dimensionless
|
Male
|
0.0488
|
Dimensionless
|
Diabetes risk
| | |
Female
|
0.5604
|
Dimensionless
|
Male
|
0.3492
|
Dimensionless
|
Hypertension risk
| | |
Female
|
0.0161
|
Dimensionless
|
Male
|
0.0152
|
Dimensionless
|
CVD beta
| | |
Calibration
|
Normal
|
−11.968
|
Dimensionless
|
Diabetes only
|
−5.53323
|
Dimensionless
|
Hypertension only
|
−6.91289
|
Dimensionless
|
Smoking only
|
−5.33926
|
Dimensionless
|
Diabetes and hypertension
|
−6.74229
|
Dimensionless
|
Diabetes and smoking
|
−8.09581
|
Dimensionless
|
Hypertension smoking
|
−7.10026
|
Dimensionless
|
Diabetes and hypertension and smoking
|
−8.18119
|
Dimensionless
|
Relative risk of CVD event Diabetes Management
|
0.8
|
Dimensionless
|
[61]
|
Relative risk of CVD event Hypertension Management
|
0.5
|
Dimensionless
|
[62]
|
Relative risk of CVD event Smoking Cessation
|
0.5
|
Dimensionless
|
Calibrated
|
CVD event death rate
|
0.2
|
Dimensionless
|
Calibrated
|
Relative risk of death CVD
|
1.6
|
Dimensionless
|
[63]
|
Effect of treatment on mortality
|
0.13
|
Dimensionless
|
[67]
|
Fraction of post-CVD population receiving treatment of risk factors
|
1
|
Dimensionless
|
Expert opinion
|